SFX by Ex Libris Inc.

Title:	Structural Basis of Proline-Specific Exopeptidase Activity as Observed in Human Dipeptidyl Peptidase-IV
Source:	Structure [0969-2126] Thoma, Ralf yr:2003

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Aertgeerts, K. "N-linked glycosylation of dipeptidyl peptidase IV (CD26): Effects on enzyme activity, homodimer formation, and adenosine deaminase binding." Protein science 13.1 (2004): 145-154.
description	2.	von Bonin, A. "Dipeptidyl-peptidase IV/CD26 on T cells: analysis of an alternative T-cell activation pathway." Immunological reviews 161 (1998): 43-53.
description	3.	Busek, P. "Dipeptidyl peptidase-IV inhibits glioma cell growth independent of its enzymatic activity." International journal of biochemistry & cell biology 44.5 (2012): 738-747.
description	4.	Weihofen, W. "Crystal structure of CD26/dipeptidyl-peptidase IV in complex with adenosine deaminase reveals a highly amphiphilic interface." The Journal of biological chemistry 279.41 (2004): 43330-43335.
description	5.	Lambeir, A M M. "Kinetic study of the processing by dipeptidyl-peptidase IV/CD26 of neuropeptides involved in pancreatic insulin secretion." FEBS letters 507.3 (2001): 327-30.
description	6.	Wesley, Umadevi V V. "Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells." International journal of cancer 109.6 (2004): 855-66.
description	7.	Shen, Ll. "Substrate specificity of DPPIV inhibitors for bioactive peptides." The FASEB journal 19.4 (2005).
description	8.	Röhrborn, D. "DPP4 in diabetes." Frontiers in immunology 6 (2015): 386-20.
description	9.	Baez, M. "Folding kinetic pathway of phosphofructokinase-2 from Escherichia coli: A homodimeric enzyme with a complex domain organization." FEBS letters 585.14 (2011): 2158-2164.
description	10.	Di Virgilio, F. "Purines, Purinergic Receptors, and Cancer." Cancer research 72.21 (2012): 5441-5447.
description	11.	Yan, S. "Enhanced ovalbumin-induced airway inflammation in CD26-/- mice." European Journal of Immunology 42.2 (2012): 533-540.
description	12.	Hiramatsu, H. "The structure and function of human dipeptidyl peptidase IV, possessing a unique eight-bladed beta-propeller fold." Biochemical and biophysical research communications 302.4 (2003): 849-854.
description	13.	Munoz, M. "The broad-spectrum antitumor action of cyclosporin A is due to its tachykinin receptor antagonist pharmacological profile." Peptides 31.9 (2010): 1643-.
description	14.	Proost, P. "Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties." Blood 98.13 (2001): 3554-3561.
description	15.	Dong, R P P. "Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response." The journal of immunology 156.4 (1996): 1349-55.
description	16.	Kobayashi, R. "Degradation of vasoactive intestinal polypeptide by rabbit gastric smooth muscle membranes." Peptides (1994): 323-32.
description	17.	Dourado, M. "CD26/DPPIV and response to hepatitis B vaccination." Pathophysiology 11.3 (2004): 147-152.
description	18.	Gallo, Richard L. "Antimicrobial peptides: an emerging concept in cutaneous biology." The Journal of investigative dermatology 111.5 (1998): 739-43.
description	19.	Kreymann, S R R. "Glucagon-like peptide-1 7-36: a physiological incretin in man." Lancet, The 2.8571 (1988): 1300-4.
description	20.	Masur, K. "DPPIV inhibitors extend GLP-2 mediated tumour promoting effects on intestinal cancer cells." Regulatory peptides 137.3 (2007): 147-155.